Garcia-Garcia D, Clavero P, Salas CG, Lamet I, Arbizu J, Gonzalez-Redondo R, et al
Common biologic pathway Doctors are taught that "if a patient has an addiction to substance A, you give them the antidote for substance A, such as a nicotine patch for tobacco, or naltrexone for alcohol," Al-Aly said
Sikiric et al., 2020b)
Enhancing CNS bioavailability through nanoparticle formulations, prodrug strategies, or intranasal delivery systems could improve therapeutic outcomes
However, evidence supporting meaningful fat loss in healthy adults is limited, and these peptides are not approved weight loss treatments
What to Expect: Initial Effects and Dosage Adjustment: Some patients may notice a decrease in appetite within the first few days of starting the medication